Filing Details
- Accession Number:
- 0001551306-24-000055
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-04-03 17:16:58
- Reporting Period:
- 2024-03-04
- Accepted Time:
- 2024-04-03 17:16:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1551306 | Progyny Inc. | PGNY | Services-Misc Health & Allied Services, Nec (8090) | 272220139 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1824161 | S. Mark Livingston | C/O Progyny, Inc. 1359 Broadway, 2Nd Fl New York NY 10018 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-03-04 | 15,000 | $0.00 | 52,248 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2024-04-01 | 20,627 | $3.95 | 72,875 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-04-01 | 11,591 | $37.64 | 61,284 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2024-04-01 | 2,129 | $37.60 | 59,155 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-01 | 9,036 | $37.62 | 50,119 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2024-03-04 | 45,000 | $0.00 | 45,000 | $35.48 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-04-01 | 20,627 | $0.00 | 20,627 | $3.95 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 45,000 | 2034-03-03 | No | 4 | A | Direct | |
| 0 | 2029-06-03 | No | 4 | M | Direct |
Footnotes
- Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). This was an annual merit grant made pursuant to the Issuer's 2019 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of Issuer common stock. 25% of the RSUs will vest on March 4, 2025 with the remaining RSUs vesting in equal quarterly installments thereafter through March 4, 2028, subject to the Reporting Person's continued service through each applicable vesting date.
- Shares withheld for payment of withholding taxes upon the exercise of stock options granted to the Reporting Person.
- Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 7, 2023.
- Represents an annual merit grant made pursuant to the Issuer's 2019 Equity Incentive Plan. 25% of the shares subject to the option will vest on March 4, 2025 with the remaining shares subject to the option vesting in equal quarterly installments thereafter through March 4, 2028, subject to the Reporting Person's continued service through each applicable vesting date.
- These options are fully vested and exercisable.
Billionaire Hedge Funds
